The significant therapeutic effects of Metformin are evident, as it effectively restores the expression of ZO-1, Claudin-1, and MUC2, potentially alleviating complications associated with T2DM through the enhancement of intestinal barrier function. This evidence concerns the gene TJP1 and type 2 diabetes mellitus.